Evaluation and validation of a point-of-care type biosensor for the measurement of S100B in plasma as a potential predictor of neurological impairment in traumatic brain injury

Traumatic brain injury (TBI) represents at least half of the trauma-related deaths, with a reported mortality rate of 37% in severe TBI. It is considered one of the significant causes of disability globally, producing high annual costs to the healthcare system. A crucial aspect in managing these pat...